BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 33845018)

  • 41. Spectral domain optical coherence tomography and autofluorescence in a case of acute posterior multifocal placoid pigment epitheliopathy mimicking Vogt-Koyanagi-Harada disease: case report and review of literature.
    Lee GE; Lee BW; Rao NA; Fawzi AA
    Ocul Immunol Inflamm; 2011 Feb; 19(1):42-7. PubMed ID: 21034311
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical and multimodal imaging characteristics of acute Vogt-Koyanagi-Harada disease unassociated with clinically evident exudative retinal detachment.
    Attia S; Khochtali S; Kahloun R; Ammous D; Jelliti B; Ben Yahia S; Zaouali S; Khairallah M
    Int Ophthalmol; 2016 Feb; 36(1):37-44. PubMed ID: 25939987
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Frequency of distinguishing clinical features in Vogt-Koyanagi-Harada disease.
    Rao NA; Gupta A; Dustin L; Chee SP; Okada AA; Khairallah M; Bodaghi B; Lehoang P; Accorinti M; Mochizuki M; Prabriputaloong T; Read RW
    Ophthalmology; 2010 Mar; 117(3):591-9, 599.e1. PubMed ID: 20036008
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Choroidal Detachment following an Intravitreal Injection in a Patient with Vogt-Koyanagi- Harada Disease.
    Kumar N; Rana N; Bansal R
    Ocul Immunol Inflamm; 2021 Feb; 29(2):396-398. PubMed ID: 31664881
    [No Abstract]   [Full Text] [Related]  

  • 45. Indocyanine green angiography in Vogt-Koyanagi-Harada disease: angiographic signs and utility in patient follow-up.
    Herbort CP; Mantovani A; Bouchenaki N
    Int Ophthalmol; 2007; 27(2-3):173-82. PubMed ID: 17457515
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical characteristics of Vogt-Koyanagi-Harada syndrome in Chinese patients.
    Yang P; Ren Y; Li B; Fang W; Meng Q; Kijlstra A
    Ophthalmology; 2007 Mar; 114(3):606-14. PubMed ID: 17123618
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vogt-Koyanagi-Harada disease in Hispanic patients.
    Sukavatcharin S; Tsai JH; Rao NA
    Int Ophthalmol; 2007; 27(2-3):143-8. PubMed ID: 17380271
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Longitudinal observation of subretinal fibrosis in Vogt-Koyanagi-Harada disease.
    Zhao C; Dong F; Gao F; Liu X; Pei M; Jia S; Zhang M
    BMC Ophthalmol; 2018 Jan; 18(1):6. PubMed ID: 29334924
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vogt-Koyanagi-Harada disease: clinical and demographic characteristics of patients in a specialized eye hospital in Turkey.
    Ozdal P; Ozdamar Y; Yazici A; Teke MY; Ozturk F
    Ocul Immunol Inflamm; 2014 Aug; 22(4):277-86. PubMed ID: 24328424
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development of Acute Vogt-Koyanagi-Harada-like Syndrome during the Treatment Course with Vemurafenib for Metastatic Melanoma.
    Apivatthakakul A; Kunavisarut P; Rothova A; Pathanapitoon K
    Ocul Immunol Inflamm; 2020 Apr; 28(3):505-508. PubMed ID: 31161956
    [No Abstract]   [Full Text] [Related]  

  • 51. Depigmented atrophic lesions in sunset glow fundi of Vogt-Koyanagi-Harada disease.
    Inomata H; Rao NA
    Am J Ophthalmol; 2001 May; 131(5):607-14. PubMed ID: 11336935
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diagnosis and classification of Vogt-Koyanagi-Harada disease.
    Sakata VM; da Silva FT; Hirata CE; de Carvalho JF; Yamamoto JH
    Autoimmun Rev; 2014; 13(4-5):550-5. PubMed ID: 24440284
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ultra-wide-field angiography findings in acute Vogt-Koyanagi-Harada disease.
    Kim P; Sun HJ; Ham DI
    Br J Ophthalmol; 2019 Jul; 103(7):942-948. PubMed ID: 30100554
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vogt-Koyanagi-Harada syndrome in a case of multiple sclerosis.
    Montero JA; Sanchis ME; Fernandez-Munoz M
    J Neuroophthalmol; 2007 Mar; 27(1):36-40. PubMed ID: 17414871
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Classification Criteria for Multifocal Choroiditis With Panuveitis.
    Standardization of Uveitis Nomenclature (SUN) Working Group
    Am J Ophthalmol; 2021 Aug; 228():152-158. PubMed ID: 33845016
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Classification Criteria for Tubercular Uveitis.
    Standardization of Uveitis Nomenclature (SUN) Working Group
    Am J Ophthalmol; 2021 Aug; 228():142-151. PubMed ID: 33845014
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sunset glow fundus in Vogt-Koyanagi-Harada disease with or without chronic ocular inflammation.
    Keino H; Goto H; Usui M
    Graefes Arch Clin Exp Ophthalmol; 2002 Oct; 240(10):878-82. PubMed ID: 12397437
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acquired myopia in Vogt-Koyanagi-Harada disease.
    Takahashi H; Takase H; Terada Y; Mochizuki M; Ohno-Matsui K
    Int Ophthalmol; 2019 Mar; 39(3):521-531. PubMed ID: 29397539
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Clinical manifestations and diagnosis of Vogt-Koyanagi-Harada syndrome].
    Yang P; Wang H; Zhou H; Huang X; Zhong H; Chen L; Zhong H; Fu T
    Zhonghua Yan Ke Za Zhi; 2002 Dec; 38(12):736-9. PubMed ID: 12654224
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diagnostic Value of Optical Coherence Tomography in the Early Diagnosis of Macular Complications in Chronic Vogt-Koyanagi-Harada Disease.
    Agarwal M; Radosavljevic A; Patnaik G; Rishi E; Pichi F
    Ocul Immunol Inflamm; 2022 May; 30(4):801-808. PubMed ID: 33136534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.